Skip to main content

Thomas Finnerty

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Thomas Finnerty

The proxy statement of Anika Therapeutics, Inc. reports total compensation of $131,287 for Thomas Finnerty in fiscal 2022, including a base salary of $77,397. Disclosed compensation is on record for 6 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Anika Therapeutics, Inc. (ANIK) $77,397 $131,287
2021 Anika Therapeutics, Inc. (ANIK) $365,900 $1,075,610
2020 Anika Therapeutics, Inc. (ANIK) $353,505 $1,143,787
2019 Anika Therapeutics, Inc. (ANIK) $341,550 $1,135,879
2018 Anika Therapeutics, Inc. (ANIK) $330,000 $758,633
2017 Anika Therapeutics, Inc. (ANIK) $44,423 $716,194

Recent activity

No call appearances or filed executive changes recorded yet.